There is no hard time limit on how long you can take meloxicam for arthritis. The FDA does not set a maximum duration. Instead, the official guidance is to use the lowest effective dose for the shortest duration that meets your treatment goals. Many people with osteoarthritis or rheumatoid arthritis take meloxicam for months or even years, but the risks of serious side effects climb the longer you stay on it, which is why ongoing monitoring matters.
Why There’s No Fixed Time Limit
Meloxicam is approved for long-term management of both osteoarthritis and rheumatoid arthritis. Unlike a course of antibiotics, it doesn’t come with a set stop date. The FDA’s prescribing guidance simply repeats one principle: lowest effective dose, shortest possible duration. That language sounds vague because the “right” duration depends entirely on how much pain relief you need, how well you tolerate the drug, and what other health risks you carry.
In practice, this means some people take meloxicam for a few weeks during a flare and then stop, while others stay on it continuously for years because their arthritis pain is constant. Neither approach is inherently wrong, but the longer you take it, the more important it becomes to weigh the benefits against accumulating risks.
How Risks Increase Over Time
Two categories of risk grow with prolonged use: cardiovascular events and gastrointestinal damage.
On the cardiovascular side, all NSAIDs (the drug class meloxicam belongs to) raise the chance of heart attack and stroke. This risk can appear early in treatment and increases with duration. It carries an FDA black box warning, the most serious type of safety alert. The risk tends to be higher at larger doses.
Gastrointestinal problems are equally concerning. Meloxicam can cause inflammation, bleeding, ulcers, and even perforation anywhere along the digestive tract, often without warning symptoms beforehand. The numbers are instructive: roughly 1% of patients treated for three to six months develop upper GI ulcers, gross bleeding, or perforation. That figure rises to 2 to 4% in patients treated for a full year. Several factors stack on top of duration to push GI risk higher, including older age, smoking, alcohol use, and taking blood thinners, corticosteroids, or certain antidepressants (SSRIs) at the same time.
Kidney and liver injury are also possible with chronic use. These problems can develop without obvious symptoms, which is why the FDA recommends periodic blood work for anyone on long-term NSAID therapy.
What Dose Matters for Safety
Meloxicam for arthritis is prescribed at either 7.5 mg or 15 mg once daily. The maximum approved dose is 15 mg per day. Doses of 22.5 mg and above have been linked to significantly more serious GI events, which is why exceeding 15 mg is not recommended.
In six-month clinical trials, GI side effects were the most common complaint at both dose levels. About 27% of patients on 7.5 mg and 24% on 15 mg reported some type of GI symptom (the similar rates likely reflect trial design rather than the lower dose being riskier). Nausea affected roughly 5% of patients at the lower dose and 7% at the higher dose. If you’re planning to stay on meloxicam long term, starting at or stepping down to 7.5 mg is a straightforward way to reduce your exposure.
Monitoring While on Long-Term Meloxicam
If you’ve been taking meloxicam for more than a few months, periodic lab work helps catch problems before they become serious. The FDA recommends a complete blood count and a chemistry panel (which covers kidney and liver function) at regular intervals for anyone on long-term NSAID therapy. There’s no universally mandated schedule, but many clinicians check these labs every six to twelve months.
Kidney function monitoring is especially important if you’re older, have heart failure, are prone to dehydration, or take blood pressure medications like ACE inhibitors or ARBs alongside meloxicam. That combination can stress the kidneys, and checking kidney markers at the start of treatment and periodically afterward is standard practice. Liver tests should also be tracked, and if they trend upward or you develop signs of liver trouble (unusual fatigue, yellowing skin, dark urine), the drug should be stopped.
Protecting Your Stomach During Extended Use
For people who need meloxicam long term but worry about GI damage, adding a proton pump inhibitor (a common type of acid-reducing medication) is one of the most effective protective strategies. PPIs help heal NSAID-related ulcers and prevent them from recurring. Research shows that consistent PPI use while taking an NSAID is directly tied to longer, safer treatment courses. Skipping PPI doses matters more than you might think: every 10% drop in adherence to a stomach-protecting medication is associated with a 16% increase in the risk of serious GI complications from NSAIDs.
If you’re over 65, have a history of stomach ulcers, or take aspirin or blood thinners alongside meloxicam, a co-prescribed PPI is particularly worth discussing with your prescriber.
Signs It May Be Time to Reassess
Even if meloxicam is working well for your arthritis pain, periodic reassessment makes sense. Some practical signals to revisit your treatment plan include:
- Stomach pain, black or tarry stools, or vomiting blood, which may indicate GI bleeding
- Swelling in the legs, unexplained weight gain, or decreased urine output, which can point to kidney stress
- Chest pain, sudden shortness of breath, or weakness on one side of the body, which are cardiovascular warning signs
- The drug no longer controls your pain as well as it once did, which may mean your arthritis has progressed and a different approach is warranted
Many rheumatologists and primary care providers will periodically suggest a “drug holiday,” a short break from meloxicam to see whether you still need it or whether your symptoms have shifted enough to try a lower dose or alternative therapy. Arthritis fluctuates, and what you needed six months ago may not match what you need today.